Management of Elevated TSH in Patients on Levothyroxine

Introduction to TSH Management

The American College of Endocrinology recommends increasing levothyroxine dose by 12.5-25 mcg to normalize TSH levels in patients with elevated TSH, with a target range of 0.5-4.5 mIU/L 1
Elevated TSH levels indicate inadequate thyroid hormone replacement, placing patients at risk for persistent hypothyroid symptoms and cardiovascular complications 1

For patients under 70 without cardiac disease, the Endocrine Society suggests increasing levothyroxine by 25 mcg 1
For patients over 70 or with cardiac disease, the American Heart Association recommends increasing levothyroxine by 12.5 mcg to prevent potential cardiac complications 1

The American Association of Clinical Endocrinologists recommends rechecking TSH and free T4 levels in exactly 6-8 weeks after dose adjustment 1
Target TSH levels should remain between 0.5-4.5 mIU/L, with free T4 levels helping to interpret ongoing abnormal TSH levels 1, 2

For patients with thyroid cancer, the American Thyroid Association suggests a lower TSH target range of 0.1-2.0 mIU/L, depending on risk stratification 3, 1
For pregnant or planning pregnancy patients, the Endocrine Society recommends increasing levothyroxine dose immediately by 25-50% and targeting a TSH level <2.5 mIU/L in the first trimester 1
For patients with cardiac disease, the American Heart Association suggests using smaller dose increments of 12.5 mcg and monitoring closely for arrhythmias and chest pain 1